March 5th of this year

　　The total investment is 2.1 billion yuan

　　The construction of the Sinopharm Health Industrial Park has officially begun

　　Entering the construction site of Sinopharm Health Industrial Park, workers are working in an orderly manner wearing safety helmets. Transport vehicles are shuttling back and forth, with dust flying everywhere. Mechanical tower cranes stand tall. All construction progress is proceeding smoothly.

　　Fu Chonglin, assistant to the chairman of Zhejiang Sinopharm Jingyue Aerosol Co., LTD.

　　Since March this year up to now, we have completed the pile foundation construction of all the main projects. Meanwhile, our four-bedroom and one-warehouse project has completed the topping-out work. This four-bedroom and one-warehouse project is expected to start trial production in June next year, while the production of other projects will take place two years later.

　　The project covers a total area of 375 mu and is constructed in two phases:

　　After the first phase reaches its full production capacity, it can form an annual production capacity of 500 million cans of aerosol, with an estimated annual output value of 5 billion yuan, which can provide employment for more than 500 people.

　　The second phase plans to acquire 191 mu of land, and the second phase project is currently under negotiation.

　　Fu Chonglin

　　This project is jointly invested by Sinopharm Group and Zhejiang Green Island Technology. Green Island Enterprise is the largest producer of aerosol products in China, while Sinopharm Group is the leader in our pharmaceutical sector. The two are a strong combination. The final product will be applied to medicinal aerosols. In the entire period, there are mainly two dosage forms, namely the aerosol and spray industries. Currently, the domestic demand for these industries is not large, but the demand for them abroad is huge.

　　It is understood that this project is jointly invested by Guotai Jiahe Hong Kong Co., LTD., a wholly-owned subsidiary of China Green Island Technology Co., LTD., Zhejiang Green Island Technology Co., LTD., Sinopharm Jingyue Aerosol Co., Ltd. and Sinopharm Materials Co., LTD. Zhejiang Sinopharm Jingyue Aerosol Co., Ltd. is established to be responsible for its operation. Committed to developing leading domestic, safe, environmentally friendly and practical medicinal and edible aerosol products.

　　Fu Chonglin

　　This project is divided into two phases. The second phase covers a total area of 191 mu. In addition to our production of aerosols, we will also apply other drug preparations of Sinopharm Group, such as solid preparations and injections, to our production in the next phase. This will help form a complete pharmaceutical industry chain.

　　Due to the special nature of its application, medicinal aeroaerosol has extremely strict requirements for the production environment, process and quality. Currently, there is still a considerable gap between China and developed countries in Europe and America in this field. Facing the huge potential domestic market, the Sinopharm Health Industrial Park project integrates the leading aerosol manufacturing production technology of Green Island Technology in China and the strong scientific research strength and resource advantages of Sinopharm in the field of traditional Chinese medicine. There are broad opportunities and hopes, and it has opened up a new development path for the Sanmen health industry.